Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
341
-
Total 13F shares, excl. options
-
70.6M
-
Shares change
-
+2.78M
-
Total reported value, excl. options
-
$3.96B
-
Value change
-
+$109M
-
Put/Call ratio
-
0.51
-
Number of buys
-
160
-
Number of sells
-
-185
-
Price
-
$56.14
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2022
425 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q2 2022.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 341 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70.6M shares
of 115M outstanding shares and own 61.24% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.46M shares), BlackRock Inc. (7.46M shares), JANUS HENDERSON GROUP PLC (6.7M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (4.56M shares), WELLINGTON MANAGEMENT GROUP LLP (3.45M shares), STATE STREET CORP (2.2M shares), Invesco Ltd. (1.89M shares), Capital Research Global Investors (1.77M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.73M shares), and Champlain Investment Partners, LLC (1.73M shares).
This table shows the top 341 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.